Chemotherapy and other non-targeted treatments Flashcards
Surgery and radiotherapy for cancer
Surgery is best treatment for removal of solid tumour. Can be used for prevention by removal of precancerous tissue. Can also be used to improve likelihood of chemo working
Radio therapy can be external beam, or internal brachytherapy.
External beam projects high energy ionising radiation on the outside of the body at the region affected. Commonly used in cancer
Internal brachytherapy plants a radioactive seed within the body.
Cell cycle overview
G1, S, G2, and M phases: drugs target M or S
S is chromosome duplication
M is mitosis.
Downsides of chemo
Targets rapidly replicating cells, including normal cells such as hair follicles, bone marrow, GIT.
Can cause several toxicities such as neutropenia, anaemia, and thrombocytopenia.
Nausea, diarrhoea, mucositis, and alopecia common.
Can cause nephro- neuro- and cardiotoxicity.
Alkylating-like agents mechanism and adverse effects
E.g., cisplatin
Platinum atom binds with genomic DNA (A and G bases) to create lesions (forms inter and intracrosslinks) which contort the DNA. This blocks DNA repair, synthesis and replication.
This affects the S cycle of the cell cycle -> G2 arrest
Used for wide range of cancers
Can cause nephrotoxicity (due to renal excretion being primary mechanism), hepatotoxicity (oxidative stress mediated), and GIT toxicity
Antimetabolites mechanism and adverse effects
e.g., methotrexate, 5-fluoruracil
Folic acid’s metabolite tetrahydrofolate is essential for DNA synthesis and repair.
Methotrexate is an analogue of folic acid, and interferes in its metabolism by competitively inhibiting dihydrofolate reductase (DHFR), preventing the formation of tetrahydrofolate.
Blocks S phase of cell cycle.
Commonly used for leukaemia, lymphoma, and solid tumours.
Can cause nephrotoxicity, hepatotoxicity, pulmonary damage, mucositis, and neurotoxicity (demyelination mechanism)
Topoisomerase Inhibitors mechanism and adverse effects
Topotecan is a topoisomerase I inhibitor.
Doxorubicin is a topoisomerase II inhibitor.
Topoisomerase enzymes regulate DNA supercoiling, with topoisomerase I causing single strand breaks, and topoisomerase II causing double strand breaks.
Both drugs inhibit the synthesis of DNA and interfere with the DNA structure.
Treat a wide range of cancers
Topotecan commonly causes myelosuppression
Doxorubicin commonly causes cardiotoxicity.
Microtubule poisons mechanism and adverse effects
e.g., vincristine, vinblastine
Treats acute lymphoblastic leukaemia.
Binds to tubulin and prevents polymerisation. This inhibits cell division (M phase of cell cycle)
Can cause cardiotoxicity, peripheral neuropathy (motor nerve damage), and GIT issues.